Bottom line
How much do VGHCX and JDOC overlap?
62% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 51.6% of VGHCX's assets and 56.1% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings VGHCX and JDOC have in common
| Holding | % of VGHCX | % of JDOC | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 8.61% | 7.76% | 7.76% |
| Merck & Co Inc | 5.44% | 4.82% | 4.82% |
| Johnson & Johnson | 4.83% | 4.82% | 4.82% |
| AstraZeneca PLC | 4.59% | 3.76% | 3.76% |
| UnitedHealth Group Inc | 4.05% | 5.85% | 4.05% |
| Gsk Plc | 3.00% | 2.47% | 2.47% |
| Edwards Lifesciences Corp | 2.56% | 1.73% | 1.73% |
| Intuitive Surgical Inc | 2.52% | 1.93% | 1.93% |
| CVS Health Corp | 2.52% | 2.83% | 2.52% |
| Cencora Inc | 2.47% | 2.07% | 2.07% |
| AbbVie Inc | 2.30% | 7.85% | 2.30% |
| Danaher Corp | 2.18% | 2.16% | 2.16% |
| Regeneron Pharmaceuticals Inc | 2.14% | 1.60% | 1.60% |
| Argenx SE | 1.68% | 2.06% | 1.68% |
| Biogen Inc | 1.46% | 1.56% | 1.46% |
| Roche Holding AG | 1.18% | 2.82% | 1.18% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in VGHCX
- Vertex Pharmaceuticals Inc — 2.36%
- Novartis AG — 1.91%
- Elevance Health Inc — 1.83%
- HCA Healthcare Inc — 1.68%
- Ucb Sa — 1.67%
- Boston Scientific Corp — 1.53%
- Agilent Technologies Inc — 1.49%
- Galderma Group AG — 1.37%
- Dexcom Inc — 1.18%
Only in JDOC
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- Novo Nordisk A/S — 2.61%
- Stryker Corp. — 2.23%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Novartis AG — 1.60%
- Cardinal Health, Inc. — 1.51%
Asset mix
| Asset type | VGHCX | JDOC |
|---|---|---|
| Stocks | 97.6% | 99.2% |
| Repurchase agreements | 2.2% | — |
| Cash & short-term funds | 0.1% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | VGHCX | JDOC |
|---|---|---|
| US | 77.6% | 75.2% |
| GB | 7.6% | 6.2% |
| JP | 4.8% | 2.5% |
| CH | 4.5% | 4.4% |
| DK | 1.4% | 4.0% |
| BE | 3.4% | — |
| NL | — | 2.4% |
| DE | — | 1.9% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do VGHCX and JDOC overlap?
What stocks do VGHCX and JDOC have in common?
Should I own both VGHCX and JDOC?
Which holds more stocks, VGHCX or JDOC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.